These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats. Oyama K, Fujimura T, Ninomiya I, Miyashita T, Kinami S, Fushida S, Ohta T, Koichi M. Carcinogenesis; 2005 Mar; 26(3):565-70. PubMed ID: 15564290 [Abstract] [Full Text] [Related]
3. Duodenal juice stimulates oesophageal stem cells to induce Barrett's oesophagus and oesophageal adenocarcinoma in rats. Miyashita T, Ohta T, Fujimura T, Ninomiya I, Fushida S, Hattori T, Miwa K. Oncol Rep; 2006 Jun; 15(6):1469-75. PubMed ID: 16685381 [Abstract] [Full Text] [Related]
4. [Cyclooxygenase (COX)-2 expression in a rat duodenoesophageal reflux model and chemoprevention of adenocarcinoma by the selective COX-2 inhibitor nimesulide]. Oyama K, Fujimura T, Ninomiya I, Miyashita T, Kinami S, Fushida S, Ohta T. Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1183-91. PubMed ID: 17675820 [Abstract] [Full Text] [Related]
5. [An experimental study on chemoprevention of esophageal adenocarcinoma by celecoxib, a selective cyclooxygenase-2 inhibitor]. Zhang T, Su LW, Zhu YF, Lang HJ, Zhang F, Zhou YA, Liang XH, Wang YJ. Zhonghua Wei Chang Wai Ke Za Zhi; 2012 May; 15(5):512-6. PubMed ID: 22648851 [Abstract] [Full Text] [Related]
11. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ. Gastroenterology; 2002 Apr; 122(4):1101-12. PubMed ID: 11910360 [Abstract] [Full Text] [Related]
12. Effect of Helicobacter pylori infection on Barrett's esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux. Liu FX, Wang WH, Wang J, Li J, Gao PP. Helicobacter; 2011 Feb; 16(1):66-77. PubMed ID: 21241415 [Abstract] [Full Text] [Related]
13. Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats. Kumagai H, Mukaisho K, Sugihara H, Miwa K, Yamamoto G, Hattori T. Carcinogenesis; 2004 May; 25(5):723-7. PubMed ID: 14754873 [Abstract] [Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Anderson LA, Johnston BT, Watson RG, Murphy SJ, Ferguson HR, Comber H, McGuigan J, Reynolds JV, Murray LJ. Cancer Res; 2006 May 01; 66(9):4975-82. PubMed ID: 16651456 [Abstract] [Full Text] [Related]
20. Chemoprevention of glandular stomach carcinogenesis through duodenogastric reflux in rats by a COX-2 inhibitor. Oba M, Miwa K, Fujimura T, Harada S, Sasaki S, Hattori T. Int J Cancer; 2008 Oct 01; 123(7):1491-8. PubMed ID: 18646190 [Abstract] [Full Text] [Related] Page: [Next] [New Search]